Method of treating anxiety-related disorders using sertraline
US4962128A · kind A · utility
20Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 1989 |
| Grant date | Oct 9, 1990 |
| Priority date | — |
| Expiry date | Nov 2, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating anxiety-related disorders comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in preventing or alleviating anxiety and the symptoms associated with anxiety-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.